Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-real catalonia

by on 13 de setembre de 2021 with No hi ha comentaris
  • Real, J., Vlacho, B., Ortega, E., Valles, J. A., Mata-Cases, M., Castelblanco, E., et al. (2021). Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-real catalonia. Cardiovascular Diabetology, 20(1), 139. https://doi.org/10.1186/s12933-021-01323-5

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *